Abhilash, P.K., Jegajeevanram, P., Prabu, P., Abdur Rahman, M., Antony Prabhu, A., Reyaz Ali Sahib, K., Govindasamy, Chandramohan, Khan, Muhammad Ibrar, Varaprasad, Kokkarachedu, and Arulselvan, Palanisamy
Metal oxide nanoparticles, such as CuO and CeOâ‚‚@CuO nanocomposites (NCs), hold significant promise for treating Methicillin-resistant Staphylococcus aureus(MRSA), Candida albicans(C. albicans) fungi, and triple-negative breast cancer (TNBC). These nanoparticles could play a crucial role in reducing the burden of antibiotic resistance, improving the treatment of fungal infections, and providing effective therapeutic options for aggressive breast cancer. Their potential in addressing these health challenges underscores their significance in future medical treatments, ultimately leading to lower healthcare costs, reduced morbidity and mortality rates, and enhanced patient quality of life.